Ankara University

Running trials

• Recruiting

  A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

  NCT06932562· Phase 3· Source

• Not yet recruiting

  Prostate Cancer Study of Patient Experiences

  NCT07096596· Source

• Recruiting

  Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue

  NCT07040657· Source

• Recruiting

  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  NCT06717347· Phase 3· Source

• Recruiting

  Post-stroke Fatigue and Clinical Parameters

  NCT07231172· Source

• Active, not recruiting

  Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)

  NCT06975917· Source

• Active, not recruiting

  A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

  NCT06161441· Phase 2· Source

• Recruiting

  A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

  NCT06056297· Phase 3· Source

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Source

• Active, not recruiting

  Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease

  NCT04166565· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Diffuse large B-cell lymphoma1 recruiting
• Endometrial cancer1 recruiting
• Multiple myeloma1 recruiting
• Prostate cancer1 recruiting
• Stroke1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Study of Daily Step Count and Treatment Response in Rectal Cancer (STEP-R)

  NCT06668402· Source

• Completed

  Evaluation of the Potential Effects of LRP5 and Tph1 in the Pathogenesis of Periodontal Disease Individuals With Stage III Grade B Periodontitis

  NCT06933797· Source

• Withdrawn

  Correlation of Serum Gasdermin-D and NLRP-3 Inflammasome Levels With GVHD Biomarkers and Endothelial Damage Markers in Graft-Versus-Host Disease

  NCT06200441· Source

• Completed

  Comparison of Occipital Nerve and Sphenopalatine Ganglion Blockade

  NCT06243874· Source

• Completed

  Effect of Omentopexy on Incisura Angularis Morphology and Gastric Emptying After Laparoscopic Sleeve Gastrectomy

  NCT07590206· Source

• Completed

  Evaluation of Hemostatic Agents in Partial Nephrectomy

  NCT07232927· Source

• Completed

  Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)

  NCT04846868· Phase 3· Source

• Terminated

  A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma

  NCT03215030· Phase 1/2· Source

Trial sites

• Ankara University6 trials
• Ankara University, Department of Hematology1 trial
• Ankara University, Faculty of Dentistry,1 trial
• Ankara University Faculty of Medicine3 trials
• Ankara University Faculty of Medicine, Department of Hematology1 trial
• Ankara University Faculty of Medicine Department of Medical Oncology1 trial
• Ankara University Faculty of Medicine, Department of Urology1 trial
• Ankara University Faculty of Medicine (Site 2801)1 trial
• Ankara University Medical School1 trial
• Ankara University School of Medicine1 trial
• Ankara Universitesi1 trial

Conditions

Diseases this institution publishes on or runs trials for.

• Prostate cancer51 works · 1 trials
• Multiple myeloma24 works · 3 trials
• Autism24 works · 0 trials
• Endometrial cancer13 works · 1 trials
• Thyroid cancer10 works · 0 trials
• Chronic lymphocytic leukaemia9 works · 0 trials
• Retinitis pigmentosa7 works · 0 trials
• Spinal muscular atrophy5 works · 0 trials
• Duchenne muscular dystrophy5 works · 0 trials
• ANCA-associated vasculitis3 works · 0 trials